Literature DB >> 25975503

HSP90 and SIRT3 expression in hepatocellular carcinoma and their effect on invasive capability of human hepatocellular carcinoma cells.

Ming Gao1, Xiao-Ping Geng2, He-Ping Xiang1.   

Abstract

OBJECTIVE: To vexplore expression of HSP90, SIRT3 in liver cancer tissue and its effect on liver cancer cell invasion ability.
METHODS: Moderate expression of HSP90 in SMMC-7721, HepG2, LO2 and Hep-3B cell lines were screened, which was validated by RT-PCR. Over-expression of HSP90 cell line and lentivirus packaging HSP90-RNAi were established, which was validated by RT-PCR and western blot. The level of epithelial-mesenchymal transition (EMT) related gene was detected by western blot. The percentage of cancer stem cells was assayed by flow cytometry.
RESULTS: RT-PCR demonstrated the highest expression of HSP90 mRNA in SMMC-7721 cells, the lowest expression of HSP90 mRNA in Hep3B and LO2 and the moderate expression of HSP90 mRNA in Hep-G2. Therefore, HepG2 was selected as a follow-up experiment cell lines. Compared with the blank control group, expression of HSP90 in HSP overexpression group was increased obviously, and expression of HSP90 in HSP90 shRNA group was significantly decreased, which indicated successful establishment of HSP overexpression and shRNA group. The apoptotic cell in hsp-siRNA group was higher than the blank control group, while the HSP overexpression group showed opposite results. Western blot results showed transfection HSP promoted cells EMT transformation, up-regulated the level of E-cadherin, and down-regulated the level of Vimentin; meanwhile, shRNA group showed opposite results.
CONCLUSIONS: Carcinoma HepG2 cell transfected high expression of HSP can promote the transformation of EMT, improve the expression of Vimentin, reduce the expression of E-cadherin, and inhibit apoptosis of cancer stem cells, which improve the invasive ability of cancer of the liver cells. While hsp-siRNA group presents opposite results. In summary, the expression of HSP is closely related to the occurrence, development and invasion of cancer of the liver tissue.
Copyright © 2015 Hainan Medical College. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer stem cell; EMT; HSP90; Liver cancer; SIRT3

Year:  2015        PMID: 25975503     DOI: 10.1016/S1995-7645(14)60335-7

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  5 in total

1.  Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients.

Authors:  Li Li; Jiangyu Zhang; Qingshan Deng; Jieming Li; Zhengfen Li; Yao Xiao; Shuiwang Hu; Tiantian Li; Qiuxiao Tan; Xiaofang Li; Bingshu Luo; Hui Mo
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

2.  Androgen receptor‑mediated upregulation of quaking affects androgen receptor‑related prostate cancer development and anti‑androgen receptor therapy.

Authors:  Keke Zhang; Fei Yan; Xiaoying Lei; Di Wei; Huanyu Lu; Zheng Zhu; An Xiang; Zichen Ye; Li Wang; Wanxiang Zheng; Xi'an Li; Jiarui Yuan; Zifan Lu; Jianlin Yuan
Journal:  Mol Med Rep       Date:  2018-04-13       Impact factor: 2.952

3.  A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma.

Authors:  Xing Fu; Yuling Yang; Xiaozhi Zhang
Journal:  Front Genet       Date:  2022-09-05       Impact factor: 4.772

4.  The Role of Heat Shock Protein 90B1 in Patients with Polycystic Ovary Syndrome.

Authors:  Li Li; Hui Mo; Jing Zhang; Yongxian Zhou; Xiuhong Peng; Xiping Luo
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

5.  SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway.

Authors:  Xiaozhen Cheng; Lingyu Qin; Lian Deng; Xiongjie Zhu; Ying Li; Xiaoran Wu; Yanfang Zheng
Journal:  J Cancer       Date:  2021-08-03       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.